logo conference-reports

Conference Reports

An educational program funded by logo MSD Oncology

JSMO 2019 - Clinical outcome of salvage chemotherapy for patients with metastatic small bowel adenocarcinoma after oxaliplatin

Limited efficacy of salvage line chemotherapy for Japanese patients with metastatic small bowel adenocarcinoma gives guidance on future drug development